🎗️
DLBCL Prognosis Calculator
Evaluate clinical prognosis for Diffuse Large B-cell Lymphoma using IPI/R-IPI criteria
Prognostic Index Guidelines: Evaluates 5 core risk factors: Age > 60 years, Elevated LDH, Performance Status (ECOG ≥ 2), Ann Arbor Stage III or IV, and > 1 Extranodal site. Select patient parameters below.
Prognostic Risk Factors Input
Calculation Results
⚠️ Not medical advice. For oncology and hematology reference only. Lymphoma staging, prognostic categorization, and treatment planning must be evaluated by a qualified hematologist or oncologist.